Edward R. O’Brien
Libin Cardiovascular Institute of Alberta
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Edward R. O’Brien.
Frontiers in Immunology | 2016
Zarah Batulan; Vivek Krishna Pulakazhi Venu; Yumei Li; Geremy Koumbadinga; Daiana Gisela Alvarez-Olmedo; Chunhua Shi; Edward R. O’Brien
Heat shock protein 27 (HSP27) is traditionally viewed as an intracellular chaperone protein with anti-apoptotic properties. However, recent data indicate that a number of heat shock proteins, including HSP27, are also found in the extracellular space where they may signal via membrane receptors to alter gene transcription and cellular function. Therefore, there is increasing interest in better understanding how HSP27 is released from cells, its levels and composition in the extracellular space, and the cognate cell membrane receptors involved in effecting cell signaling. In this paper, the knowledge to date, as well as some emerging paradigms about the extracellular function of HSP27 is presented. Of particular interest is the role of HSP27 in attenuating atherogenesis by modifying lipid uptake and inflammation in the plaque. Moreover, the abundance of HSP27 in serum is an emerging new biomarker for ischemic events. Finally, HSP27 replacement therapy may represent a novel therapeutic opportunity for chronic inflammatory disorders, such as atherosclerosis.
Trends in Cardiovascular Medicine | 2013
Cecilia T. Costiniuk; Benjamin Hibbert; Trevor Simard; Feras M. Ghazawi; Jonathan B. Angel; Edward R. O’Brien
Human immunodeficiency virus (HIV)-infected individuals have a cardiovascular disease risk that is almost thrice than that of their HIV-uninfected counterparts. Given the critical role of endothelial progenitor cells (EPCs) in vascular homeostasis and arterial repair postinjury, coupled with their strength as biomarkers predictive of cardiovascular events, interest has arisen in characterizing EPCs in the context of HIV infection. We conducted a systematic review of the literature to determine the current state of knowledge on EPCs in the context of HIV infection. Herein, we summarize the pertinent findings of these studies and discuss important differences in the subpopulations of EPCs examined and the methodologies used for their enumeration which likely contributed to the heterogeneity observed across studies.
PLOS ONE | 2015
Jingti Deng; Xiu-Ling Wang; Yongxiang Chen; Edward R. O’Brien; Yu Gui; Michael P. Walsh
Rho-associated kinase (ROCK) and zipper-interacting protein kinase (ZIPK) have been implicated in diverse physiological functions. ROCK1 phosphorylates and activates ZIPK suggesting that at least some of these physiological functions may require both enzymes. To test the hypothesis that sequential activation of ROCK1 and ZIPK is commonly involved in regulatory pathways, we utilized siRNA to knock down ROCK1 and ZIPK in cultured human arterial smooth muscle cells (SMC). Microarray analysis using a whole-transcript expression chip identified changes in gene expression induced by ROCK1 and ZIPK knockdown. ROCK1 knockdown affected the expression of 553 genes, while ZIPK knockdown affected the expression of 390 genes. A high incidence of regulation of transcription regulator genes was observed in both knockdowns. Other affected groups included transporters, kinases, peptidases, transmembrane and G protein-coupled receptors, growth factors, phosphatases and ion channels. Only 76 differentially expressed genes were common to ROCK1 and ZIPK knockdown. Ingenuity Pathway Analysis identified five pathways shared between the two knockdowns. We focused on cytokine signaling pathways since ROCK1 knockdown up-regulated 5 and down-regulated 4 cytokine genes, in contrast to ZIPK knockdown, which affected the expression of only two cytokine genes (both down-regulated). IL-6 gene expression and secretion of IL-6 protein were up-regulated by ROCK1 knockdown, whereas ZIPK knockdown reduced IL-6 mRNA expression and IL-6 protein secretion and increased ROCK1 protein expression, suggesting that ROCK1 may inhibit IL-6 secretion. IL-1β mRNA and protein levels were increased in response to ROCK1 knockdown. Differences in the effects of ROCK1 and ZIPK knockdown on cell cycle regulatory genes suggested that ROCK1 and ZIPK regulate the cell cycle by different mechanisms. ROCK1, but not ZIPK knockdown reduced the viability and inhibited proliferation of vascular SMC. We conclude that ROCK1 and ZIPK have diverse, but predominantly distinct regulatory functions in vascular SMC and that ROCK1-mediated activation of ZIPK is not involved in most of these functions.
The FASEB Journal | 2017
Vivek Krishna Pulakazhi Venu; Ayinuer Adijiang; Tara Seibert; Yongxiang Chen; Chunhua Shi; Zarah Batulan; Edward R. O’Brien
Circulation | 2014
Chunhua Shi; Yuan Zhang; Yongxiang Chen; Edward R. O’Brien
Women's Midlife Health | 2018
Zarah Batulan; Nadia Maarouf; Vipul Shrivastava; Edward R. O’Brien
The FASEB Journal | 2018
Chunhua Shi; Annegret Ulke-Lemée; Jingti Deng; Zarah Batulan; Edward R. O’Brien
Clinical Science | 2018
Michael H. Chiu; Bobak Heydari; Zarah Batulan; Nadia Maarouf; Vinita Subramanya; Karin Schenck-Gustafsson; Edward R. O’Brien
Atherosclerosis Supplements | 2018
Nadia Maarouf; Vipul Shrivastava; Zarah Batulan; Edward R. O’Brien
Atherosclerosis Supplements | 2018
Yong-Xiang Chen; Chunhua Shi; Jingti Deng; Catherine Diao; Matthew Clarkson; Vipul Shrivastava; Ayinuer Adijiang; Angie Hu; Michael H. Chiu; Brenig Gwilym; Alexandria Hellmich; Christopher Malozzi; Zarah Batulan; Edward R. O’Brien; William T. Gerthoffer